PhRMA expresses ‘serious concerns’ with Trump drug pricing proposals

By Peter Sullivan; The Hill ~ May 15, 2018

The main drug industry lobbying group on Tuesday said that it had “serious concerns” with major elements of President Trump’s new plan to bring down drug prices.

In the first extended remarks on the plan since Trump unveiled it last Friday, Lori Reilly, an executive vice president of the Pharmaceutical Research and Manufacturers of America (PhRMA), pointed to several proposals she said would harm patient access to drugs.



6 Ways Trump’s Drug Price Plan Could Lower Rx Costs

By Lisa L. Gill; Consumer Reports ~ May 11, 2018

President Donald Trump today outlined a set of proposals that he hopes will lower the high and increasing cost of prescription drugs for millions of Americans.

If enacted, the most dramatic changes could alter how drugs are purchased and sold among drug companies, insurers, and industry middlemen, fundamentally restructuring a complex, decades-old system.



Social Security Beneficiaries Top 62,000,000 for First Time

By Terence P. Jeffrey; CNS News ~ May 07, 2018

(CNSNews.com) – In the first quarter of 2018, the number of Social Security beneficiaries topped 62,000,000 for the first time, according to data released by the Social Security Administration.

In fact, people receiving Social Security benefits in the United States now outnumber the population of Italy.

Social Security ended the fourth quarter of 2017 with 61,903,360 beneficiaries. By the end of the first quarter of this year, that had risen to 62,233,678—an increase of 330,318 in three months.



Three Things People Often Get Wrong About Social Security, And Why It’s Critical To Get It Right

From Beau Henderson; Forbes ~ May 07, 2018

My eyes were opened to the predicament many Americans face when filing for Social Security one afternoon when I had lunch with a mentor who happened to be a successful businessman. When he reached full retirement age at 66, he filed for his benefits because the local SSA office told him, “Even though you’re still working, you might as well claim your benefit because there’s no longer a cap on what you can earn.”



Opinion: Medically tailored food is the future of health care

From Karen Pearl; The Hill ~ May 07, 2018

Imagine you’re living with type 2 diabetes. You’ve been trying to manage the condition for years with a typical medication. What if instead of metformin — a drug that works to lower sugar in the blood, — our doctor could simply prescribe meals tailored to your unique diagnosis that help control your blood sugar?



Today’s Special: Obamacare Menu Labeling Rules Ushered In

By Phil Galewitz; Kaiser Health News ~ May 07, 2018

Restaurants, convenience stores, vending machines and pizza delivery services are among the businesses that will have to provide calories counts to consumers. Many restaurant chains, including McDonald’s, Burger King, Taco Bell and Panera Bread, have listed calorie information for years.



Opinion: A New Snapshot Of Older Adults In The U.S.

From Howard Gleckman; Forbes ~ May 04, 2018

It is easy—and dangerous—to create stereotypes of older adults. Just when you think you have a picture in your head of what a senior is, you realize how very different they are. To borrow a phrase: You’ve seen one older adult and, you’ve seen one older adult.



How Inflation Can Ruin Your Retirement

From Robert Laura; Forbes ~ Apr 30, 2018

Consumer prices and wages are on the rise and that means one thing: Inflation. It’s not only a hot topic and showing up in more news reports, but it’s also catching people off guard and has the potential to create some real pain for those near or already in retirement. Here’s how:



Dissecting The Rhetoric Vs. Reality Of Trump’s Tough Talk On Drug Prices

By Sarah Jane Tribble; Kaiser Health News ~ Apr 27, 2018

President Donald Trump has railed against the high price of prescription drugs and famously bemoaned how pharmaceutical companies are “getting away with murder.” Yet, many Americans aren’t seeing a change in what they pay out-of-pocket.

Trump promised a speech on prescription drug prices, and it’s expected anytime.



How High Drug Prices and Big Lobbying Budgets Go Together for Big Pharma

By Jay Hancock & Elizabeth Lucas; Fortune ~ Apr 26, 2018

This article was produced in partnership with Kaiser Health News.

The outlook was grim for Novo Nordisk at the end of 2016. As pressure mounted over the pharmaceutical giant’s rising insulin prices, investors drove its stock down by a third, fearing that policymakers would cap price tags and hurt profits.





Archives by Category:



Reminder to Members

Please notify us at: E-mail if you change your contact information, particularly your e-mail address so you continue to receive information from us.



Healthcare reform act passed by congress. It explains just about everything one would want to know about the new law and outlines when certain provisions become effective.